PIpepTolDC
/ City of Hope
- LARVOL DELTA
Home
Next
Prev
1 to 8
Of
8
Go to page
1
September 17, 2025
An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes
(clinicaltrials.gov)
- P1 | N=6 | Active, not recruiting | Sponsor: City of Hope Medical Center | Trial completion date: Jun 2025 ➔ Dec 2025
Trial completion date • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus • HLA-DRB1
January 04, 2025
An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes
(clinicaltrials.gov)
- P1 | N=6 | Active, not recruiting | Sponsor: City of Hope Medical Center | Recruiting ➔ Active, not recruiting | Trial completion date: Dec 2024 ➔ Jun 2025 | Trial primary completion date: Dec 2024 ➔ Jun 2025
Enrollment closed • Trial completion date • Trial primary completion date • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus • CD14 • HLA-DRB1
April 13, 2023
An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes
(clinicaltrials.gov)
- P1 | N=7 | Recruiting | Sponsor: City of Hope Medical Center | Trial completion date: Oct 2023 ➔ Oct 2024 | Trial primary completion date: Oct 2023 ➔ Oct 2024
Trial completion date • Trial primary completion date • Diabetes • Hypoglycemia • Metabolic Disorders • Type 1 Diabetes Mellitus • CD14 • CD4 • HLA-DRB1 • IL10
August 18, 2021
An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes
(clinicaltrials.gov)
- P1; N=7; Recruiting; Sponsor: City of Hope Medical Center; Trial completion date: Oct 2022 ➔ Oct 2023; Initiation date: May 2021 ➔ Oct 2021; Trial primary completion date: Oct 2022 ➔ Oct 2023
Clinical • Trial completion date • Trial initiation date • Trial primary completion date • Diabetes • Hypoglycemia • Metabolic Disorders • Type 1 Diabetes Mellitus • CD14 • CD4 • HLA-DRB1 • IL10
February 11, 2021
An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes
(clinicaltrials.gov)
- P1; N=7; Recruiting; Sponsor: City of Hope Medical Center; Initiation date: Jan 2021 ➔ May 2021
Clinical • Trial initiation date • Diabetes • Hypoglycemia • Metabolic Disorders • Type 1 Diabetes Mellitus • CD14 • CD4 • HLA-DRB1 • IL10
December 17, 2020
An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes
(clinicaltrials.gov)
- P1; N=7; Recruiting; Sponsor: City of Hope Medical Center; Initiation date: Oct 2020 ➔ Jan 2021
Clinical • Trial initiation date • Diabetes • Hypoglycemia • Metabolic Disorders • Type 1 Diabetes Mellitus • CD14 • HLA-DRB1 • IL10
October 20, 2020
An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes
(clinicaltrials.gov)
- P1; N=7; Recruiting; Sponsor: City of Hope Medical Center; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Diabetes • Hypoglycemia • Metabolic Disorders • Type 1 Diabetes Mellitus
October 19, 2020
An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes
(clinicaltrials.gov)
- P1; N=7; Not yet recruiting; Sponsor: City of Hope Medical Center
Clinical • New P1 trial • Diabetes • Hypoglycemia • Metabolic Disorders • Type 1 Diabetes Mellitus
1 to 8
Of
8
Go to page
1